Quick Answer
PRECISION BIOSCIENCES INC reported Cash and Equivalents of $110.82 million for fiscal year 2025.
PRECISION BIOSCIENCES INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $110.82M | +29.0% |
| 2024 | $85.90M | -26.4% |
| 2023 | $116.68M | -38.5% |
| 2022 | $189.58M | +32.0% |
| 2021 | $143.66M | +60.0% |
| 2020 | $89.80M | -50.4% |
| 2019 | $180.89M | +75.3% |
| 2018 | $103.19M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $44.87M | -54.6% | -27.9% |
| June 30, 2025 | $62.24M | -49.6% | -19.4% |
| March 31, 2025 | $77.22M | -43.9% | -10.1% |
| December 31, 2024 | $85.90M | -26.4% | -13.0% |
| September 30, 2024 | $98.75M | -19.2% | -20.1% |
| June 30, 2024 | $123.57M | -10.3% | -10.3% |
| March 31, 2024 | $137.77M | -12.9% | +18.1% |
| December 31, 2023 | $116.68M | -38.5% | -4.5% |
- PRECISION BIOSCIENCES INC showed an increase of +29.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2018–2025 period, PRECISION BIOSCIENCES INC’s cash and equivalents has grown by 7.4% (from $103.19 million to $110.82 million).
- The most recent figure is from PRECISION BIOSCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: